The prognosis of the high-risk PFS group showed a clear trend, but this difference was not statistically significant.
← all excerpts
A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients.
1
—
—
The prognosis of the high-risk PFS group showed a clear trend, but this difference was not statistically significant.